Today’s AI Top Pick: PODD

8/3/2026 · Bullish Consensus Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PODD83%314 resolved forecasts · 45d window · verify →

Today's pick · Bullish Consensus Reliable BullishPODDBUY NOW8.7 / 108/3/2026

Insulet (PODD) is the cleanest confluence of a deep pullback setup with explosive forward forecasts and a fundamental profile that already passed the screen. The stock sits ~27.7% below its weekly 21-bar high with only 23.5% position in the weekly range and 51.8% on the daily — this is NOT a chase; it's the tape offering a discounted entry into a name that has already de-risked (perfYear -42.67%, perfYtd -41.83%). Meanwhile, the Kronos forecasts are among the strongest in the entire pool: 1d mid/long +49.94%/+61.35%, 4h mid/long +53.4%/+59.25%, and 1wk long +63.23%. Bullish_prob = 1.0 and near_term_bullish = 0.8 with all four timeframes pointing higher (1h fc +8-12%, 4h +18-59%, 1d +15-61%, 1wk +11-63%). Fundamentals are legitimately strong: salesYoY 31.93%, epsNextY estimate +24.25%, roe 23%, peg 0.77, profitMargin 10.44%, debt/eq manageable at 0.73, and analysts back it (recom 1.54, targetUpsidePct +40.5%). Yes, trailing PE of 38.49 looks rich, but fwdPe of 20.53 is reasonable for a medtech growing 30%+ with insulin-pump category leadership. Fundamental score is 8/8. The headline flow is clean — the most recent items are an earnings preview and a 'Quality Affordable Growth Stock' write-up, with no guidance cut, no legal overhang, no dilution risk. Compare to alternatives: PDD has better fundamentals but is glued to 99-100% range position on 1h/4h/1d (chasing risk); MNSO has cheapest peg (0.17) and recom 1.17 but was just downgraded to Hold; FUTU has a DOJ probe hanging over it; FICO just had its worst drop in six years; TMUS's Deutsche Telekom deal hit a roadblock; FRSH's forecasts are all negative despite passing the screen. TODAY is the right entry because you're getting: (a) 1h at 100% range but forecasts still up +8-12% suggesting momentum continuation, (b) 1wk position at 23.5% giving you 40%+ headroom before hitting resistance, (c) an imminent Q2 catalyst, and (d) the deepest forecast magnitudes in the top-quality-fundamentals cohort. Waiting risks missing the gap-and-go into earnings.

Entry zone

$160 - $166 (current $164.28; scale in on any dip toward the 5-day base, add on a decisive break above $168)

Stop loss

$148 (below the 1wk drawdown structure, ~10% risk — invalidates the pullback thesis)

First target

$185 - $190 (fill of the weekly gap, aligns with 4h/1d short-horizon forecasts)

Longer target

$220 - $235 (roughly the 1wk long-horizon forecast +40% to +60% zone; analyst target upside 40.5% ≈ $231)

Risks

Q2 2026 earnings imminent — any guidance miss or CGM competitive commentary from Dexcom/Abbott could invalidate the setup (stock is -42.67% over the past year, sentiment fragile)
Trailing PE 38.49 and short float 6.74% mean any disappointment gets punished hard; consensus expects sequential improvement
1h position at 100% of range means a same-day gap-fill of 2-4% is likely before the sustained move
Healthcare/medtech reimbursement or FDA-related headlines could hit the sector broadly
Weekly downtrend still intact until $200 reclaimed — this is a counter-trend buy against a -27.66% weekly drawdown

Honorable mentions

PDDBest pure fundamentals in the pool (fwdPe 7.15, peg 0.64, debt/eq 0.01, profitMargin 21.86%) with all four TFs pointing up and 1d/1wk forecasts +18-27%. Downgraded to #2 only because 1h/4h/1d position is 99-100% of range — you'd be chasing. Buy on any pullback to $82-84.

MNSOCheapest peg in the entire pool (0.17), strongest recom (1.17), near_term_bullish 1.0, and forecast magnitudes are massive (4h +37-49%, 1d +34-41%). Held back by a July 28 SeekingAlpha downgrade to Hold and near-top range positioning on shorter TFs.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PODD	BUY NOW	8.7	Deep -27.7% weekly pullback + all-TF bullish forecasts (1d mid +49.9%, 1wk long +63.2%), clean news, imminent earnings catalyst.
2	PDD	BUY PULLBACK	8.3	Best fundamentals in pool (fwdPe 7.15, zero debt) with 4-TF alignment, but 99-100% range position argues for waiting on a dip.
3	MNSO	BUY NOW	8.1	Peg 0.17, recom 1.17, near_term 1.0, 1d fc +34-41%; SeekingAlpha Hold downgrade is the only smudge.
4	ACM	BUY NOW	7.9	All-TF aligned (1h/4h/1d fc +16-36%), Lisbon airport contract catalyst, recom 1.38, 1wk range only 26%.
5	WAY	BUY NOW	7.7	1d fc +40.7% short/+39.8% mid, recom 1.16 (best in pool), 1d range position 18% — room to run.
6	TCOM	BUY NOW	7.6	PE 7.4, profitMargin 48.4%, antitrust probe resolved without major overhaul, 1d fc +23.8-33.1%.
7	TRMB	BUY NOW	7.4	Full 4-TF alignment, near_term_bullish 1.0, 1wk position 40%, no negative news.
8	TMDX	BUY PULLBACK	7.3	Huge forecasts (1d +37-57%, 1h +28-31%) but 23% short float and 1h at 100% range = chase risk.
9	ZTS	BUY PULLBACK	7.1	Deep -31.8% weekly drawdown with 1wk fc +38-119%, but 1h long-horizon fc turns negative (-13.3%).
10	INTU	BUY PULLBACK	6.9	1d/1wk forecasts explosive (+49% to +86%) but 1h/4h short-term forecasts negative — wait for base.
11	CRM	BUY NOW	6.7	Cramer/Motley Fool positive spin, 1d fc +11.7-19.3%, but 1h at 99% range and 1h fc negative.
12	TMUS	WAIT	6.4	Strong fundamentals (recom 1.42, targetUpside 41.1%) but Deutsche Telekom merger roadblock is a live overhang.
13	MLCO	BUY NOW	6.3	peg 0.36, 1wk fc mid/long +36.7/+52.9%, but small cap ($2.2B) and 1h fc slightly negative.
14	ADSK	BUY PULLBACK	6.2	near_term 1.0, positive 'undervalued' narrative, but bullish_prob 0.8 and 4h fc short slightly negative.
15	SAP	WAIT	6.0	Solid growth but limited signal data and RSI 64.6 puts it near the screen boundary.
16	MMS	BUY PULLBACK	5.9	PE 9.0, fwdPe 6.6, targetUpside 74.3%, but 1h fc negative and salesYoY -1.4%.
17	BR	WAIT	5.7	1h forecasts sharply negative (-15 to -18%) despite good fundamentals; earnings tomorrow is binary.
18	STEP	WAIT	5.6	Negative ROE -750, operMargin -45.6%, profitMargin -26.7% — screen passer with broken profitability.
19	ONON	WAIT	5.5	1wk position 47.6%, decent forecasts but 1wk fc mid -9.4% and 1h fc essentially flat.
20	SE	WAIT	5.3	1h fc -14.6%, 4h fc short -12.2%, RSI stretched; wait for Shopee Q2 print.
21	TME	WAIT	5.2	1h fc -6% and peg 4.46; the 4h/1d strong forecasts (+40-76%) aren't confirmed on short TFs.
22	CCC	WAIT	5.0	PE 86.4, 1h fc -16 to -18%, offset partially by 1wk fc long +84%.
23	AUGO	WAIT	4.8	epsNextY negative, only positive 1yr performer here (+123.9%), 1h/1d forecasts weakly positive.
24	FRMI	AVOID	4.5	No fundamentals (null revenue/margin), speculative real-estate/data-center play, no bullish_prob.
25	FUTU	WAIT	4.3	DOJ probe and Hong Kong SFC asset freeze headline overhang despite strong short-TF forecasts.
26	CLBT	WAIT	4.1	CEO sold 103k shares, 1h/4h fc negative, PE 51.8; wait for basing.
27	NOW	AVOID	3.9	Just announced 300 job cuts, 1h fc -20.6%, 4h fc -12.5% — deteriorating tape into a rich valuation (PE 69.5).
28	FICO	AVOID	3.5	Worst 6-year single-day drop just occurred; 1h/1wk forecasts still negative, catch-a-falling-knife setup.
29	PLTR	AVOID	3.2	1wk fc mid/long -34.9%/-46.1%, PE 138 and PS 56.5, extreme valuation with weakening long-horizon tape.
30	FRSH	AVOID	2.5	Bullish_prob 0, ALL forecasts across all TFs negative (1h -22%, 4h -14%, 1d -5%, 1wk -13%) — passed screen but tape is broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord